Company intelligence / Profile preview

OVETEK

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

OveTek is a biotechnology company focused on the development of innovative therapies and diagnostic tools for ovarian cancer. Founded by experts in gynecologic oncology, the company leverages advanced research into the molecular drivers of ovarian malignancies to identify novel therapeutic targets. OveTek's primary mission is to improve survival rates and quality of life for women diagnosed with this challenging disease through precision medicine approaches. The company is currently advancing its research programs through pre-clinical stages, aiming to translate laboratory findings into clinical applications.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on OVETEK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OVETEK.

Explore the full profile